Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Clofazimine effectively treated ashy dermatosis in a patient.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

AQB reduces harmful skin changes in systemic sclerosis.

The FDA approved a new Pfizer drug for hair loss in teens.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Etanercept effectively treated a severe skin condition when other treatments failed.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.